Source: Northwestern University

Cannabis is widely used for its calming, euphoric, and stress-relieving properties. Yet clinicians and recreational users have long recognized an unpredictable paradox: for some individuals, or at higher doses, cannabinoids can induce severe acute anxiety, catastrophic thinking, and panic attacks. This adverse reaction is especially common when consumption coincides with unpredictable, frightening, or stressful surroundings.

With the rapid legalization and commercial availability of high-potency THC products across the United States, emergency department admissions related to cannabis-induced acute panic and psychotic-like episodes have climbed substantially.

While scientists understood that cannabinoids bind to cannabinoid type 1 (CB1) receptors across the brain, the precise cellular switch determining whether cannabis soothes or inflames anxiety has remained elusive.

Now, a team of neuroscientists at the Northwestern University Feinberg School of Medicine has identified the exact neuronal ensemble responsible for this switch.

Published in Nature Communications, the research reveals that cannabinoids disinhibit a tiny enclave of fear-processing cells, known as somatostatin neurons, within the central amygdala, leaving the brain hyper-reactive to perceived threats.

“The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis or the situation they are in turns stressful or scary,” said study senior author Sachin Patel, M.D., Ph.D., Chair of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine.

Tracking Threat Perception in the Living Brain

To investigate this phenomenon, the research team placed mice in an arena exposed to an innate predator threat cue, an odorant derived from fox urine. Prior to exposure, mice received either an inert placebo or varying doses of a synthetic cannabinoid.

Using head-mounted miniature fluorescent microscopes (miniscopes), the scientists monitored the real-time calcium dynamics of individual neurons as the mice freely explored the testing arena.

The behavioral results were immediate: mice treated with cannabinoids froze significantly more often, exhibited exaggerated avoidance, and spent far less time investigating the scent than control animals.

Electrophysiological recordings from brain tissue slices uncovered the cellular mechanism behind this response:

  • Disrupting the Inhibitory Brake: Under normal baseline conditions, GABAergic inhibitory inputs act as a natural brake to keep somatostatin-positive neurons in the central amygdala quiet.
  • Synergistic Hyperactivation: Cannabinoids dismantle this regulatory brake. When paired with the perceptual stress of a predator scent, the lack of inhibition causes somatostatin neurons to fire excessively.

“Higher doses of cannabinoids and environmental stress worked together to synergistically release the ‘brake’ on the central amygdala, which in turn drove excessive anxiety,” Dr. Patel explained.

Silencing the Neural Circuit Rescues Behavior

To confirm whether these specific neurons were actively generating the anxiety state, the Northwestern investigators used targeted chemogenetic and genetic tools to selectively silence somatostatin neurons in the central amygdala.

Once these cells were turned off, the cannabinoid-induced fear response collapsed: despite receiving the drug, the animals ceased their excessive freezing and resumed normal, non-panicked investigation of their environment.

The findings establish that central amygdala somatostatin neurons serve as a direct gateway for cannabinoid-mediated behavioral distress.

Broader Implications for Clinical Anxiety Disorders

The discovery carries major public health implications as cannabis potency continues to rise alongside global rates of mood and anxiety disorders.

“Understanding how cannabis affects brain function to generate its psychoactive effects could ultimately reveal new ways to counteract negative consequences should they arise in some people,” Dr. Patel noted.

Crucially, the therapeutic implications extend far beyond treating cannabis side effects. Because the central amygdala acts as a primary coordinator for fear, trauma, and autonomic distress, modulating this specific subpopulation of cells could offer a blueprint for developing next-generation therapeutics for generalized anxiety disorder, panic disorder, and post-traumatic stress disorder (PTSD).

“Suppressing the activity of somatostatin neurons in the central amygdala could represent a final pathway for reducing anxiety symptoms, not just in the context of cannabis side effects,” Dr. Patel concluded.

Keywords; neuroscience, anxiety